Skip to main content
Andreas Schlitzer
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Highly Cited Researchers 2022

ImmunoSensation is prominently represented in the “Highly Cited Researchers 2022” ranking

The Bonn Cluster of Excellence ImmunoSensation2 once more is strongly represented in this year’s ranking of highly cited researchers. Prof. Eicke Latz, head of the Institute of Innate Immunity at the University Hospital Bonn, Prof. Andreas Schlitzer, head of the Quantitative Systems Biology group at LIMES Institute of Bonn University as well as Prof. Joachim Schultze, Director Systems Medicine at the DZNE, are among the year’s most influential researchers once more.

The researchers on the list of "Highly Cited Researchers" are among the world's most influential one percent of their scientific field, according to the creators of the ranking. The benchmark is the frequency with which their scientific publications have been cited by other scientists in the last ten years (period from 2011 to 2021). The ranking is published annually by the Web of Science Group and includes around 6,200 scientists in 21 subject categories.

Prof. Eicke Latz is awarded as one of the most influential researchers in the field of immunology for the nineth time in a row. He has been ranked as one of the “highly cited researchers” every single year, since 2014. Prof. Andreas Schlitzer receives the award for the fourth time. He has been ranked as “highly cited researcher” in cross-Field annually, starting 2019. Prof. Joachim Schultze is ranked for the second time. He had been among the “highly cited researchers” in cross-Field in 2021 and this year belongs to the most influential researchers in the field of immunology.

The full list of researchers is published by web of science and can be found at https://clarivate.com/highly-cited-researchers/

Related news

Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview